Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peritransplant immunosuppression with ATG, rituximab, sirolimus and mycophenolate mofetil in mismatched allogeneic hematopoietic cell transplantation
2011-002192-41Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Dec 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolate mofetil, sirolimus, antithymocyte globulin rabbit, rituximab in hematopoietic malignancies, leukemia, lymphoma, sponsored by University Hospital Tübingen. Started Dec 2011; status: completed.
02
Drugs
mycophenolate mofetilsirolimusantithymocyte globulin rabbitrituximab
03
Conditions
hematopoietic malignanciesleukemialymphoma
Beyond the preview
Go deeper on 2011-002192-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002192-41.